Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380083312> ?p ?o ?g. }
- W4380083312 abstract "Background Antidepressants still have some side effects in treating major depressive disorder (MDD), and acupuncture therapy is a complementary therapy of research interest for MDD. Acupoints are sensitive sites for disease response and stimulation points for acupuncture treatment. Prior studies suggest that the biological specificity of acupoints is altered in physiological and pathological situations. Therefore, we hypothesize that the biological specificity of acupoints is associated with the diagnosis of MDD and that stimulating acupoints with significant biological specificity can achieve a better therapeutic effect than clinical common acupoints. This study aims to investigate the efficacy and safety of intradermal acupuncture (IA) treatment for MDD based on changes in the biological specificity of acupoints. Methods The first part of the study will enroll 30 MDD patients and 30 healthy control (HC) participants to assess pain sensitivity and thermal specificity of MDD-related acupoints using a pressure pain threshold gauge (PTG) and infrared thermography (IRT). The potentially superior acupoints for treating MDD will be selected based on the results of PTG and IRT tests and referred to as pressure pain threshold strong response acupoints (PSA) and temperature strong response acupoints (TSA). The second part of the study will enroll 120 eligible MDD patients randomly assigned to waiting list (WL) group, clinical common acupoint (CCA) group, TSA group, and PSA group in a 1:1:1:1 ratio. The change in the Patient Health Questionnaire-9 Items (PHQ-9), the MOS item short-form health survey (SF-36), pressure pain threshold, temperature of acupoints, and adverse effects will be observed. The outcomes of PHQ-9 and SF-36 measures will be assessed before intervention, at 3 and 6 weeks after intervention, and at a 4-week follow-up. The biological specificity of acupoint measures will be assessed before intervention and at 6 weeks after intervention. All adverse effects will be assessed. Discussion This study will evaluate the therapeutic effect and safety of IA for MDD based on changes in the biological specificity of acupoints. It will investigate whether there is a correlation between the biological specificity of MDD-related acupoints and the diagnosis of MDD and whether stimulating strong response acupoints is superior to clinical common acupoints in the treatment of MDD. The study’s results may provide insights into the biological mechanisms of acupuncture and its potential as a complementary therapy for MDD. Clinical Trial Registration ClinicalTrials.gov , identifier: NCT05524519." @default.
- W4380083312 created "2023-06-10" @default.
- W4380083312 creator A5000707511 @default.
- W4380083312 creator A5001175377 @default.
- W4380083312 creator A5008195963 @default.
- W4380083312 creator A5022303593 @default.
- W4380083312 creator A5035416765 @default.
- W4380083312 creator A5039972019 @default.
- W4380083312 creator A5055328951 @default.
- W4380083312 creator A5061519111 @default.
- W4380083312 creator A5070020475 @default.
- W4380083312 creator A5075180888 @default.
- W4380083312 creator A5082020327 @default.
- W4380083312 creator A5090731919 @default.
- W4380083312 creator A5091348325 @default.
- W4380083312 date "2023-06-09" @default.
- W4380083312 modified "2023-09-25" @default.
- W4380083312 title "The effective on intradermal acupuncture based on changes in biological specificity of acupoints for major depressive disorder: study protocol of a prospective, multicenter, randomized, controlled trial" @default.
- W4380083312 cites W1598268316 @default.
- W4380083312 cites W1828776044 @default.
- W4380083312 cites W1960878161 @default.
- W4380083312 cites W1963543274 @default.
- W4380083312 cites W1979275798 @default.
- W4380083312 cites W2011063704 @default.
- W4380083312 cites W2030994963 @default.
- W4380083312 cites W2040550783 @default.
- W4380083312 cites W2049870581 @default.
- W4380083312 cites W2057468507 @default.
- W4380083312 cites W2096856326 @default.
- W4380083312 cites W2113750014 @default.
- W4380083312 cites W2132322340 @default.
- W4380083312 cites W2134973672 @default.
- W4380083312 cites W2166023752 @default.
- W4380083312 cites W2292381980 @default.
- W4380083312 cites W2356925553 @default.
- W4380083312 cites W2477696699 @default.
- W4380083312 cites W2512716401 @default.
- W4380083312 cites W2766775334 @default.
- W4380083312 cites W2767793280 @default.
- W4380083312 cites W2915221544 @default.
- W4380083312 cites W2917016288 @default.
- W4380083312 cites W2926046275 @default.
- W4380083312 cites W2939580427 @default.
- W4380083312 cites W2991970297 @default.
- W4380083312 cites W3001424269 @default.
- W4380083312 cites W3088017223 @default.
- W4380083312 cites W3092849554 @default.
- W4380083312 cites W3141705336 @default.
- W4380083312 cites W3162526451 @default.
- W4380083312 cites W3198387241 @default.
- W4380083312 cites W3202660027 @default.
- W4380083312 cites W3203310594 @default.
- W4380083312 cites W4205900283 @default.
- W4380083312 cites W4297681341 @default.
- W4380083312 cites W4367679113 @default.
- W4380083312 doi "https://doi.org/10.3389/fpsyt.2023.1183127" @default.
- W4380083312 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37441145" @default.
- W4380083312 hasPublicationYear "2023" @default.
- W4380083312 type Work @default.
- W4380083312 citedByCount "0" @default.
- W4380083312 crossrefType "journal-article" @default.
- W4380083312 hasAuthorship W4380083312A5000707511 @default.
- W4380083312 hasAuthorship W4380083312A5001175377 @default.
- W4380083312 hasAuthorship W4380083312A5008195963 @default.
- W4380083312 hasAuthorship W4380083312A5022303593 @default.
- W4380083312 hasAuthorship W4380083312A5035416765 @default.
- W4380083312 hasAuthorship W4380083312A5039972019 @default.
- W4380083312 hasAuthorship W4380083312A5055328951 @default.
- W4380083312 hasAuthorship W4380083312A5061519111 @default.
- W4380083312 hasAuthorship W4380083312A5070020475 @default.
- W4380083312 hasAuthorship W4380083312A5075180888 @default.
- W4380083312 hasAuthorship W4380083312A5082020327 @default.
- W4380083312 hasAuthorship W4380083312A5090731919 @default.
- W4380083312 hasAuthorship W4380083312A5091348325 @default.
- W4380083312 hasBestOaLocation W43800833121 @default.
- W4380083312 hasConcept C126322002 @default.
- W4380083312 hasConcept C142724271 @default.
- W4380083312 hasConcept C168563851 @default.
- W4380083312 hasConcept C1862650 @default.
- W4380083312 hasConcept C197934379 @default.
- W4380083312 hasConcept C204787440 @default.
- W4380083312 hasConcept C2779144063 @default.
- W4380083312 hasConcept C2780051608 @default.
- W4380083312 hasConcept C535046627 @default.
- W4380083312 hasConcept C56837625 @default.
- W4380083312 hasConcept C71924100 @default.
- W4380083312 hasConceptScore W4380083312C126322002 @default.
- W4380083312 hasConceptScore W4380083312C142724271 @default.
- W4380083312 hasConceptScore W4380083312C168563851 @default.
- W4380083312 hasConceptScore W4380083312C1862650 @default.
- W4380083312 hasConceptScore W4380083312C197934379 @default.
- W4380083312 hasConceptScore W4380083312C204787440 @default.
- W4380083312 hasConceptScore W4380083312C2779144063 @default.
- W4380083312 hasConceptScore W4380083312C2780051608 @default.
- W4380083312 hasConceptScore W4380083312C535046627 @default.
- W4380083312 hasConceptScore W4380083312C56837625 @default.
- W4380083312 hasConceptScore W4380083312C71924100 @default.
- W4380083312 hasFunder F4320335784 @default.
- W4380083312 hasLocation W43800833121 @default.
- W4380083312 hasLocation W43800833122 @default.